{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:05:58Z","timestamp":1792641958408,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10549-022-06654-9","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:05:21Z","timestamp":1655816721000},"page":"617-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Added value of repeat sentinel lymph node biopsy in FDG-PET\/CT node-negative patients with ipsilateral breast cancer recurrence"],"prefix":"10.1007","volume":"194","author":[{"given":"R.","family":"Haarsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"van Loevezijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Donswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T. F. D.","family":"Vrancken Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-4049","authenticated-orcid":false,"given":"F. H.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"6654_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1470-2045(17)30777-5","volume":"19","author":"B Asselain","year":"2018","unstructured":"Asselain B, Barlow W, Bartlett J, Bergh J, Bergsten-Nordstr\u00f6m E, Bliss J, Boccardo F, Boddington C, Bogaerts J, Bonadonna G, Bradley R, Brain E, Braybrooke J, Broet P, Bryant J, Burrett J, Cameron D, Clarke M, Coates A, Coleman R, Coombes RC, Correa C, Costantino J, Cuzick J, Danforth D, Davidson N, Davies C, Davies L, Di Leo A, Dodwell D, Dowsett M, Duane F, Evans V, Ewertz M, Fisher B, Forbes J, Ford L, Gazet J-C, Gelber R, Gettins L, Gianni L, Gnant M, Godwin J, Goldhirsch A, Goodwin P, Gray R, Hayes D, Hill C, Ingle J, Jagsi R, Jakesz R, James S, Janni W, Liu H, Liu Z, Lohrisch C, Loibl S, MacKinnon L, Makris A, Mamounas E, Mannu G, Mart\u00edn M, Mathoulin S, Mauriac L, McGale P, McHugh T, Morris P, Mukai H, Norton L, Ohashi Y, Olivotto I, Paik S, Pan H, Peto R, Piccart M, Pierce L, Poortmans P, Powles T, Pritchard K, Ragaz J, Raina V, Ravdin P, Read S, Regan M, Robertson J, Rutgers E, Scholl S, Slamon D, S\u00f6lkner L, Sparano J, Steinberg S, Sutcliffe R, Swain S, Taylor C, Tutt A, Valagussa P, van de Velde C, van der Hage J, Viale G, von Minckwitz G et al (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19:27\u201339. https:\/\/doi.org\/10.1016\/s1470-2045(17)30777-5","journal-title":"Lancet Oncol"},{"key":"6654_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejca.2018.07.124","volume":"102","author":"MC van Maaren","year":"2018","unstructured":"van Maaren MC, Strobbe LJA, Smidt ML, Moossdorff M, Poortmans PMP, Siesling S (2018) Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: taking account of event-free years. Eur J Cancer 102:82\u201394. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.124","journal-title":"Eur J Cancer"},{"key":"6654_CR3","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1245\/s10434-019-07545-y","volume":"26","author":"Z Al-Hilli","year":"2019","unstructured":"Al-Hilli Z, Grobmyer SR (2019) Management strategies for locally recurrent breast cancer: redo-lumpectomy, redo-sentinel node biopsy, redo-radiation. Ann Surg Oncol 26:3018\u20133024. https:\/\/doi.org\/10.1245\/s10434-019-07545-y","journal-title":"Ann Surg Oncol"},{"key":"6654_CR4","unstructured":"(NABON) NBON (2012 with revision in 2017) Richtlijn behandeling van het mammacarcinoom."},{"key":"6654_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/bjs.10289","volume":"103","author":"M Ahmed","year":"2016","unstructured":"Ahmed M, Baker R, Rubio IT (2016) Meta-analysis of aberrant lymphatic drainage in recurrent breast cancer. Br J Surg 103:1579\u20131588. https:\/\/doi.org\/10.1002\/bjs.10289","journal-title":"Br J Surg"},{"key":"6654_CR6","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1245\/s10434-014-4282-5","volume":"22","author":"M Intra","year":"2015","unstructured":"Intra M, Viale G, Vila J, Grana CM, Toesca A, Gentilini O, Galimberti V, Veronesi P, Luini A, Rotmensz N, Bagnardi V, Mattar D, Colleoni M (2015) Second axillary sentinel lymph node biopsy for breast tumor recurrence: experience of the European Institute of Oncology. Ann Surg Oncol 22:2372\u20132377. https:\/\/doi.org\/10.1245\/s10434-014-4282-5","journal-title":"Ann Surg Oncol"},{"key":"6654_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-013-2409-1","volume":"138","author":"AJ Maaskant-Braat","year":"2013","unstructured":"Maaskant-Braat AJ, Voogd AC, Roumen RM, Nieuwenhuijzen GA (2013) Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat 138:13\u201320. https:\/\/doi.org\/10.1007\/s10549-013-2409-1","journal-title":"Breast Cancer Res Treat"},{"key":"6654_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/bjs.11097","volume":"106","author":"IGM Poodt","year":"2019","unstructured":"Poodt IGM, Vugts G, Schipper RJ, Roumen RMH, Rutten HJT, Maaskant-Braat AJG, Voogd AC, Nieuwenhuijzen GAP, Sentinel Node and Recurrent Breast Cancer (SNARB) Research Group (2019) Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence. Br J Surg 106:574\u2013585. https:\/\/doi.org\/10.1002\/bjs.11097","journal-title":"Br J Surg"},{"key":"6654_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-015-3571-4","volume":"153","author":"G Vugts","year":"2015","unstructured":"Vugts G, Maaskant-Braat AJ, Voogd AC, van Riet YE, Luiten EJ, Rutgers EJ, Rutten HJ, Roumen RM, Nieuwenhuijzen GA (2015) Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer. Breast Cancer Res Treat 153:549\u2013556. https:\/\/doi.org\/10.1007\/s10549-015-3571-4","journal-title":"Breast Cancer Res Treat"},{"key":"6654_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/annonc\/mdu118","volume":"25","author":"H Bonnefoi","year":"2014","unstructured":"Bonnefoi H, Litiere S, Piccart M, MacGrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmstrom P, Werutsky G, Bogaerts J, Bergh J, Cameron DA, EORTC 10994\/BIG 1-00 Study investigators (2014) Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994\/BIG 1\u201300 phase III trial. Ann Oncol 25:1128\u20131136. https:\/\/doi.org\/10.1093\/annonc\/mdu118","journal-title":"Ann Oncol"},{"key":"6654_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE, Pazdur R, Ditsch N, Rastogi P, Eiermann W, von Minckwitz G (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. The Lancet 384:164\u2013172. https:\/\/doi.org\/10.1016\/s0140-6736(13)62422-8","journal-title":"The Lancet"},{"key":"6654_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s40265-017-0774-5","volume":"77","author":"TG Steenbruggen","year":"2017","unstructured":"Steenbruggen TG, van Ramshorst MS, Kok M, Linn SC, Smorenburg CH, Sonke GS (2017) Neoadjuvant therapy for breast cancer: established concepts and emerging strategies. Drugs 77:1313\u20131336. https:\/\/doi.org\/10.1007\/s40265-017-0774-5","journal-title":"Drugs"},{"key":"6654_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13014-019-1367-0","volume":"14","author":"A Sato","year":"2019","unstructured":"Sato A, Sakai T, Iwase T, Kano F, Kimura K, Ogiya A, Koizumi M, Tanabe M, Horii R, Akiyama F, Ueno T, Ohno S (2019) Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence. Radiat Oncol 14:159. https:\/\/doi.org\/10.1186\/s13014-019-1367-0","journal-title":"Radiat Oncol"},{"key":"6654_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1245\/s10434-009-0841-6","volume":"17","author":"IM van der Ploeg","year":"2010","unstructured":"van der Ploeg IM, Oldenburg HS, Rutgers EJ, Baas-Vrancken Peeters MJ, Kroon BB, Valdes Olmos RA, Nieweg OE (2010) Lymphatic drainage patterns from the treated breast. Ann Surg Oncol 17:1069\u20131075. https:\/\/doi.org\/10.1245\/s10434-009-0841-6","journal-title":"Ann Surg Oncol"},{"key":"6654_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10549-019-05205-z","volume":"175","author":"IGM Poodt","year":"2019","unstructured":"Poodt IGM, Schipper RJ, de Greef BTA, Vugts G, Maaskant-Braat AJG, Jansen FH, Wyndaele DNJ, Voogd AC, Nieuwenhuijzen GAP, Sentinel Node and Recurrent Breast Cancer (SNARB) Research Group (2019) Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval. Breast Cancer Res Treat 175:419\u2013428. https:\/\/doi.org\/10.1007\/s10549-019-05205-z","journal-title":"Breast Cancer Res Treat"},{"key":"6654_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1245\/s10434-012-2625-7","volume":"20","author":"AJ Maaskant-Braat","year":"2013","unstructured":"Maaskant-Braat AJ, Roumen RM, Voogd AC, Pijpers R, Luiten EJ, Rutgers EJ, Nieuwenhuijzen GA (2013) Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol 20:620\u2013626. https:\/\/doi.org\/10.1245\/s10434-012-2625-7","journal-title":"Ann Surg Oncol"},{"key":"6654_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1245\/s10434-018-6358-0","volume":"25","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Vugts G, Schipper RJ, Nieuwenhuijzen GAP (2018) Repeat sentinel lymph node biopsy for ipsilateral breast tumor recurrence: a systematic review of the results and impact on prognosis. Ann Surg Oncol 25:1329\u20131339. https:\/\/doi.org\/10.1245\/s10434-018-6358-0","journal-title":"Ann Surg Oncol"},{"key":"6654_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2017.75.5389","volume":"36","author":"HB Neuman","year":"2018","unstructured":"Neuman HB (2018) Risk of synchronous distant recurrence at time of locoregional recurrence in patients with stage II and III breast cancer (AFT-01). J Clin Oncol 36:975\u2013980. https:\/\/doi.org\/10.1200\/JCO.2017.75.5389","journal-title":"J Clin Oncol"},{"key":"6654_CR19","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1200\/JCO.2001.19.6.1688","volume":"19","author":"AC Voogd","year":"2001","unstructured":"Voogd AC (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688\u20131697","journal-title":"J Clin Oncol"},{"key":"6654_CR20","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1200\/JCO.2008.17.1496","volume":"26","author":"D Fuster","year":"2008","unstructured":"Fuster D, Duch J, Paredes P, Velasco M, Munoz M, Santamaria G, Fontanillas M, Pons F (2008) Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography\/computed tomography compared with conventional imaging procedures. J Clin Oncol 26:4746\u20134751. https:\/\/doi.org\/10.1200\/JCO.2008.17.1496","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"6654_CR21","doi-asserted-by":"publisher","first-page":"17S","DOI":"10.2967\/jnumed.115.157859","volume":"57","author":"D Groheux","year":"2016","unstructured":"Groheux D, Cochet A, Humbert O, Alberini JL, Hindie E, Mankoff D (2016) (1)(8)F-FDG PET\/CT for Staging and Restaging of Breast Cancer. J Nucl Med 57(Suppl 1):17S-26S. https:\/\/doi.org\/10.2967\/jnumed.115.157859","journal-title":"J Nucl Med"},{"key":"6654_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-012-2179-1","volume":"135","author":"BB Koolen","year":"2012","unstructured":"Koolen BB, Valdes Olmos RA, Elkhuizen PH, Vogel WV, Vrancken Peeters MJ, Rodenhuis S, Rutgers EJ (2012) Locoregional lymph node involvement on 18F-FDG PET\/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Breast Cancer Res Treat 135:231\u2013240. https:\/\/doi.org\/10.1007\/s10549-012-2179-1","journal-title":"Breast Cancer Res Treat"},{"key":"6654_CR23","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1007\/s00330-015-3630-6","volume":"25","author":"J Krammer","year":"2015","unstructured":"Krammer J, Schnitzer A, Kaiser CG, Buesing KA, Sperk E, Brade J, Wasgindt S, Suetterlin M, Schoenberg SO, Sutton EJ, Wasser K (2015) (18) F-FDG PET\/CT for initial staging in breast cancer patients\u2014is there a relevant impact on treatment planning compared to conventional staging modalities? Eur Radiol 25:2460\u20132469. https:\/\/doi.org\/10.1007\/s00330-015-3630-6","journal-title":"Eur Radiol"},{"key":"6654_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1245\/s10434-018-7058-5","volume":"26","author":"AA van Loevezijn","year":"2019","unstructured":"van Loevezijn AA, Bartels SAL, van Duijnhoven FH, Heemsbergen WD, Bosma SCJ, Elkhuizen PHM, Donswijk ML, Rutgers EJT, Oldenburg HSA, Vrancken Peeters M, van der Ploeg IMC (2019) Internal mammary chain sentinel nodes in early-stage breast cancer patients: toward selective removal. Ann Surg Oncol 26:945\u2013953. https:\/\/doi.org\/10.1245\/s10434-018-7058-5","journal-title":"Ann Surg Oncol"},{"key":"6654_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6654_CR26","unstructured":"Breast Cancer Guideline, NABON 2012. Dutch Guideline, Version 2.0, 2012. https:\/\/www.oncoline.nl\/uploaded\/docs\/mammacarcinoom\/Dutch%20Breast%20Cancer%20Guideline%202012.pdf."},{"key":"6654_CR27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41416-018-0052-7","volume":"118","author":"JS Liikanen","year":"2018","unstructured":"Liikanen JS, Leidenius MH, Joensuu H, Vironen JH, Meretoja TJ (2018) Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study. Br J Cancer 118:1529\u20131535. https:\/\/doi.org\/10.1038\/s41416-018-0052-7","journal-title":"Br J Cancer"},{"key":"6654_CR28","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","volume":"26","author":"SM Wong","year":"2019","unstructured":"Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA (2019) Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 26:3502\u20133509. https:\/\/doi.org\/10.1245\/s10434-019-07517-2","journal-title":"Ann Surg Oncol"},{"key":"6654_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1072-7515(02)01268-1","volume":"195","author":"ER Port","year":"2002","unstructured":"Port ER (2002) Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195:167\u2013172","journal-title":"J Am Coll Surg"},{"key":"6654_CR30","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1245\/s10434-006-9237-z","volume":"14","author":"ER Port","year":"2007","unstructured":"Port ER, Garcia-Etienne CA, Park J, Fey J, Borgen PI, Cody HS 3rd (2007) Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 14:2209\u20132214. https:\/\/doi.org\/10.1245\/s10434-006-9237-z","journal-title":"Ann Surg Oncol"},{"key":"6654_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1470-7330-14-13","volume":"22","author":"ADS Cochet","year":"2014","unstructured":"Cochet ADS, Moodie K et al (2014) The utility of 18 F-FDG PET\/CT for suspected recurrent breast cancer: impact and prognostic stratification. Cancer Imaging 22:13","journal-title":"Cancer Imaging"},{"key":"6654_CR32","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","volume":"27","author":"SJ Anderson","year":"2009","unstructured":"Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP, Wolmark N (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27:2466\u20132473. https:\/\/doi.org\/10.1200\/JCO.2008.19.8424","journal-title":"J Clin Oncol"},{"key":"6654_CR33","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","volume":"24","author":"IL Wapnir","year":"2006","unstructured":"Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, Fisher B, Wolmark N (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028\u20132037. https:\/\/doi.org\/10.1200\/JCO.2005.04.3273","journal-title":"J Clin Oncol"},{"key":"6654_CR34","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1200\/JCO.2017.76.5719","volume":"36","author":"IL Wapnir","year":"2018","unstructured":"Wapnir IL, Price KN, Anderson SJ, Robidoux A, Martin M, Nortier JWR, Paterson AHG, Rimawi MF, Lang I, Baena-Canada JM, Thurlimann B, Mamounas EP, Geyer CE Jr, Gelber S, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S et al (2018) Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial. J Clin Oncol 36:1073\u20131079. https:\/\/doi.org\/10.1200\/JCO.2017.76.5719","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06654-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06654-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06654-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T04:25:23Z","timestamp":1657859123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06654-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6654"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06654-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The institutional review board of the Netherlands Cancer Institute approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study was conducted retrospectively from data obtained for clinical purposes. An official waiver of ethical approval was granted from the institutional review board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}